Local recommendations (Cardiovascular)
Diuretics
| Recommendation | Approval date | Review date |
| Hydrochlorothiazide EKPG EKHUFT | February 2019 | February 2022 |
Hypertension and Heart Failure
| Recommendation | Approval date | Review date |
| EKPG Recommendation - Sacubitril Valsartan | November 2016 | November 2019 |
| Sacubitril Valsartan GP letter | June 2016 | April 2021 |
| Sacubitril valsartan GP summary | June 2016 | April 2021 |
| Midodrine prescribing information sheet (V2) | April 2016 | April 2021 |
| B195. Doxazosin MR 2.0 | January 2018 | January 2021 |
Nitrates, calcium-channel blockers, and other antianginal drugs
| Recommendation | Approval date | Review date |
| Chronic Heart Failure -ECK Ivabradine NICE TA 267 | July 2015 | April 2021 |
Lipid modifying drugs
| Recommendation | Approval date | Review date |
| Alirocumab & Evoculumab, GP update on Implementation of NICE TAs 393 & 394 | November 2017 | November 2020 |
| EKPG Recommendation - Evolocumab and alirocumab for hypercholesterolaemia | April 2017 | April 2020 |
| Implementation Guidance for NICE TA 694 - Bempedoic Acid | September 2021 | September 2022 |
| Summary of national guidance for lipid management for primary and secondary prevention of CVD | April 2022 | April 2023 |
| Kent & Medway ICB Position Statement for Prescribing Inclisiran | July 2023 | July 2025 |
Antithrombotic drugs
| Recommendation | Approval date | Review date |
| Enoxaparin pre surgery EKPG recommendation | July 2015 | April 2021 |
| EKPG Recommendation - NOACs - DVT PE treatment | August 2018 | August 2021 |
| Ticagrelor for the prevention of atherothrombotic events in adult patients with ACS, EKPG | August 2013 | April 2021 |
| EKPG Recommendation - Argatroban for type 2 heparin-induced thrombocytopenia | March 2017 | March 2020 |
| Factsheet - Inhixa (Enoxaparin) | October 2020 | October 2022 |
|
See NICE guidance for choice of anticoagulation in AF: https://www.nice.org.uk/guidance/ng196 Please consider choice of anticoagulant in light of COVID-19 with reference to national guidance (here) and MHRA advice (here). |
December 2021 | December 2023 |
| KMCCG Joint Prescribing Committee (JPC) Position Statement and Risk Mitigation Principles for anticoagulant prescribing | June 2022 | June 2023 |
General (Cardio)
| Recommendation | Approval date | Review date |
| Rituximab for the treatment of immune thrombocytopenic purpura, EKPG Recommendation | December 2015 | April 2021 |
| Dapagliflozin in CKD guide | June 2022 | June 2024 |